Fluvoxamine may decrease the clearance (and therefore increase the levels) of cinacalcet, by inhibiting its
metabolism by CYP1A2.
It may be prudent to monitor parathyroid hormone and
serum calcium more frequently if
fluvoxamine is started or stopped. Note that other
SSRIs do not inhibit CYP1A2 and are therefore unlikely to interact by this mechanism.